Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.

MLA

Gerardi, Savannah, et al. “Implementation of Targeted Deprescribing of Potentially Inappropriate Medications in Patients on Hemodialysis.” American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists, vol. 79, no. Suppl 4, Nov. 2022, pp. S128–35. EBSCOhost, https://doi.org/10.1093/ajhp/zxac190.

APA

Gerardi, S., Sperlea, D., Levy, S. O.-L., Bondurant-David, K., Dang, S., David, P.-M., Lizotte, A., Senécal, L., Paquette, F., & Vanier, M.-C. (2022). Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis. American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists, 79(Suppl 4), S128–S135. https://doi.org/10.1093/ajhp/zxac190

Chicago

Gerardi, Savannah, David Sperlea, Shirel Ora-Lee Levy, Kaitlin Bondurant-David, Sébastien Dang, Pierre-Marie David, Annie Lizotte, Lysane Senécal, François Paquette, and Marie-Claude Vanier. 2022. “Implementation of Targeted Deprescribing of Potentially Inappropriate Medications in Patients on Hemodialysis.” American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists 79 (Suppl 4): S128–35. doi:10.1093/ajhp/zxac190.